Zdrowie i gospodarka · 14/02/2019
FDA Announces Draft Guidance for Informal Recognition of Voluntary Consensus Standards in Pharmaceutical Quality
The FDA is releasing a draft guidance outlining a proposed program to publicly recognize voluntary consensus standards related to pharmaceutical quality, aiming to promote innovation and streamline the review process for pharmaceutical products.
Source: Federal Register — Food and Drug AdministrationOpen original release →